APA

Barathan M., Mariappan V., Shankar E. M., Abdullah B. J. J., Goh K. L. & Vadivelu J. (20140225). Hypericin-photodynamic therapy leads to interleukin-6 secretion by HepG2 cells and their apoptosis via recruitment of BH3 interacting-domain death agonist and caspases. : Cell death & disease.

Chicago

Barathan M, Mariappan V, Shankar E M, Abdullah B J J, Goh K L and Vadivelu J. 20140225. Hypericin-photodynamic therapy leads to interleukin-6 secretion by HepG2 cells and their apoptosis via recruitment of BH3 interacting-domain death agonist and caspases. : Cell death & disease.

Harvard

Barathan M., Mariappan V., Shankar E. M., Abdullah B. J. J., Goh K. L. and Vadivelu J. (20140225). Hypericin-photodynamic therapy leads to interleukin-6 secretion by HepG2 cells and their apoptosis via recruitment of BH3 interacting-domain death agonist and caspases. : Cell death & disease.

MLA

Barathan M, Mariappan V, Shankar E M, Abdullah B J J, Goh K L and Vadivelu J. Hypericin-photodynamic therapy leads to interleukin-6 secretion by HepG2 cells and their apoptosis via recruitment of BH3 interacting-domain death agonist and caspases. : Cell death & disease. 20140225.